{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:38:23Z","timestamp":1790757503345,"version":"4.1.0"},"reference-count":121,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"JMC Legacy Research Fund of Germans Trias i Pujol University Hospital"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Kidneys have an amazing ability to adapt to adverse situations, both acute and chronic. In the presence of injury, the kidney is able to activate mechanisms such as autoregulation or glomerular hyperfiltration to maintain the glomerular filtration rate (GFR). While these adaptive mechanisms can occur in physiological situations such as pregnancy or high protein intake, they can also occur as an early manifestation of diseases such as diabetes mellitus or as an adaptive response to nephron loss. Although over-activation of these mechanisms can lead to intraglomerular hypertension and albuminuria, other associated mechanisms related to the activation of inflammasome pathways, including endothelial and tubular damage, and the hemodynamic effects of increased activity of the renin\u2013angiotensin\u2013aldosterone system, among others, are recognized pathways for the development of albuminuria. While the role of albuminuria in the progression of chronic kidney disease (CKD) is well known, there is increasing evidence of its negative association with cardiovascular events. For example, the presence of albuminuria is associated with an increased likelihood of developing heart failure (HF), even in patients with normal GFR, and the role of albuminuria in atherosclerosis has recently been described. Albuminuria is associated with adverse outcomes such as mortality and HF hospitalization. On the other hand, it is increasingly known that the systemic effects of congestion are mainly preceded by increased central venous pressure and transmitted retrogradely to organs such as the liver or kidney. With regard to the latter, a new entity called congestive nephropathy is emerging, in which increased renal venous pressure can lead to albuminuria. Fortunately, the presence of albuminuria is modifiable and new treatments are now available to reverse this common risk factor in the cardiorenal interaction.<\/jats:p>","DOI":"10.3390\/jcm13030777","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T11:35:34Z","timestamp":1706614534000},"page":"777","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Albuminuria, Forgotten No More: Underlining the Emerging Role in CardioRenal Crosstalk"],"prefix":"10.3390","volume":"13","author":[{"given":"Gregorio","family":"Romero-Gonz\u00e1lez","sequence":"first","affiliation":[{"name":"Nephrology Department, Germans Trias i Pujol University Hospital, 08916 Badalona, Spain"},{"name":"REMAR-IGTP Group (Kidney-Affecting Diseases Research Group), Germans Trias i Pujol Research Institute (IGTP), 08916 Badalona, Spain"},{"name":"International Renal Research Institute of Vicenza, 36100 Vicenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00e9stor","family":"Rodr\u00edguez-Chitiva","sequence":"additional","affiliation":[{"name":"Nephrology Department, Germans Trias i Pujol University Hospital, 08916 Badalona, Spain"},{"name":"REMAR-IGTP Group (Kidney-Affecting Diseases Research Group), Germans Trias i Pujol Research Institute (IGTP), 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Ca\u00f1ameras","sequence":"additional","affiliation":[{"name":"Nephrology Department, Germans Trias i Pujol University Hospital, 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Pa\u00fal-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Nephrology Department, Germans Trias i Pujol University Hospital, 08916 Badalona, Spain"},{"name":"REMAR-IGTP Group (Kidney-Affecting Diseases Research Group), Germans Trias i Pujol Research Institute (IGTP), 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Urrutia-Jou","sequence":"additional","affiliation":[{"name":"Nephrology Department, University Hospital Joan XXIII, 43005 Tarragona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribel","family":"Troya","sequence":"additional","affiliation":[{"name":"Nephrology Department, Germans Trias i Pujol University Hospital, 08916 Badalona, Spain"},{"name":"REMAR-IGTP Group (Kidney-Affecting Diseases Research Group), Germans Trias i Pujol Research Institute (IGTP), 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Soler-Majoral","sequence":"additional","affiliation":[{"name":"Nephrology Department, Germans Trias i Pujol University Hospital, 08916 Badalona, Spain"},{"name":"REMAR-IGTP Group (Kidney-Affecting Diseases Research Group), Germans Trias i Pujol Research Institute (IGTP), 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredzzia","family":"Graterol Torres","sequence":"additional","affiliation":[{"name":"Nephrology Department, Germans Trias i Pujol University Hospital, 08916 Badalona, Spain"},{"name":"REMAR-IGTP Group (Kidney-Affecting Diseases Research Group), Germans Trias i Pujol Research Institute (IGTP), 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"S\u00e1nchez-Bay\u00e1","sequence":"additional","affiliation":[{"name":"Nephrology Department, Germans Trias i Pujol University Hospital, 08916 Badalona, Spain"},{"name":"REMAR-IGTP Group (Kidney-Affecting Diseases Research Group), Germans Trias i Pujol Research Institute (IGTP), 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6806-9539","authenticated-orcid":false,"given":"Jordi","family":"Calabia","sequence":"additional","affiliation":[{"name":"Nephrology Department, University Hospital Josep Trueta, IdIBGi Research Institute, Universitat de Girona, 17007 Girona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3577-2273","authenticated-orcid":false,"given":"Jordi","family":"Bover","sequence":"additional","affiliation":[{"name":"Nephrology Department, Germans Trias i Pujol University Hospital, 08916 Badalona, Spain"},{"name":"REMAR-IGTP Group (Kidney-Affecting Diseases Research Group), Germans Trias i Pujol Research Institute (IGTP), 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1056\/NEJMra2201153","article-title":"Uses of GFR and Albuminuria Level in Acute and Chronic Kidney Disease","volume":"386","author":"Levey","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal Syndrome","volume":"52","author":"Ronco","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"E840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement from the American Heart Association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ejhf.1697","article-title":"Evaluation of kidney function throughout the heart failure trajectory\u2014A position statement from the Heart Failure Association of the European Society of Cardiology","volume":"22","author":"Mullens","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_5","first-page":"817","article-title":"Heart failure in chronic kidney disease: The emerging role of myocardial fibrosis","volume":"37","author":"Ravassa","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41581-018-0101-8","article-title":"Evolving concepts in the pathogenesis of uraemic cardiomyopathy","volume":"15","author":"Wang","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/CIRCULATIONAHA.117.028814","article-title":"Cardiorenal syndrome revisited","volume":"138","author":"Zannad","year":"2018","journal-title":"Circulation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/ckj\/sfx023","article-title":"Clinical proteomics in kidney disease as an exponential technology: Heading towards the disruptive phase","volume":"10","author":"Sanz","year":"2017","journal-title":"Clin. Kidney J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.kint.2020.02.010","article-title":"Nomenclature for kidney function and disease: Report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference","volume":"97","author":"Levey","year":"2020","journal-title":"Kidney Int."},{"key":"ref_10","first-page":"1","article-title":"Kidney disease: Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Levin","year":"2013","journal-title":"Kidney Int. Suppl."},{"key":"ref_11","unstructured":"Writing Group for the CKD Prognosis Consortium, Appel, L.J., Grams, M., Woodward, M., Harris, K., Arima, H., Chalmers, J., Yatsuya, H., Tamakoshi, K., and Li, Y. (2023). Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis. JAMA, 330, 1266\u20131277."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ncpgasthep0680","article-title":"Drug Insight: The role of albumin in the management of chronic liver disease","volume":"4","author":"Wong","year":"2007","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Paar, M., Fengler, V.H., Rosenberg, D.J., Krebs, A., Stauber, R.E., Oettl, K., and Hammel, M. (2021). Albumin in patients with liver disease shows an altered conformation. Commun. Biol., 4.","DOI":"10.1038\/s42003-021-02269-w"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fphys.2014.00299","article-title":"Unraveling the mysteries of serum albumin-more than just a serum protein","volume":"5","author":"Merlot","year":"2014","journal-title":"Front. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1152\/physrev.00014.2021","article-title":"Albumin Uptake and Processing by the Proximal Tubule: Physiological, Pathological, and Therapeutic Implications","volume":"102","author":"Molitoris","year":"2022","journal-title":"Physiol. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11897-019-0424-1","article-title":"Diuretic Resistance in Heart Failure","volume":"16","author":"Gupta","year":"2019","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jacc.2022.10.028","article-title":"Albuminuria and Heart Failure: JACC State-of-the-Art Review","volume":"81","author":"Khan","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.kint.2023.10.002","article-title":"Tubular handling of filtered albumin","volume":"104","author":"Devuyst","year":"2023","journal-title":"Kidney Int."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Gburek, J., Konopska, B., and Go\u0142\u0105b, K. (2021). Renal Handling of Albumin\u2014From Early Findings to Current Concepts. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115809"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2215\/CJN.09400913","article-title":"The Glomerulus: The Sphere of Influence","volume":"9","author":"Pollak","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41572-020-0196-7","article-title":"Podocytopathies","volume":"6","author":"Kopp","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJMra1808786","article-title":"Insights into Glomerular Filtration and Albuminuria","volume":"384","author":"Benzing","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"991756","DOI":"10.3389\/fphys.2022.991756","article-title":"New insights into proteinuria\/albuminuria","volume":"13","author":"Comper","year":"2022","journal-title":"Front. Physiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41581-022-00559-y","article-title":"Glomerular hyperfiltration","volume":"18","author":"Cortinovis","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/eurheartj\/ehac612","article-title":"Rethinking albuminuria as a marker to drive treatment in congestive heart failure","volume":"44","author":"Pugliese","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejim.2019.10.025","article-title":"Creatinine: From physiology to clinical application","volume":"72","author":"Kashani","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/eurheartj\/ehac683","article-title":"Prevention of cardiorenal damage: Importance of albuminuria","volume":"44","author":"Ruilope","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e2326230","DOI":"10.1001\/jamanetworkopen.2023.26230","article-title":"Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease","volume":"6","author":"Chu","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e2348333","DOI":"10.1001\/jamanetworkopen.2023.48333","article-title":"Urinary Albumin-to-Creatinine Ratio in Normal Range, Cardiovascular Health, and All-Cause Mortality","volume":"6","author":"Mahemuti","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies with the special contribution of the European Association of Preventive Cardiology (EAPC)","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.nefro.2023.02.004","article-title":"Art\u00edculo especial por el D\u00eda Mundial del Ri\u00f1\u00f3n: Las sociedades cient\u00edficas espa\u00f1olas ante la gu\u00eda ESC 2021 de prevenci\u00f3n de la enfermedad vascular: Generalizar la medida de la albuminuria para identificar el riesgo vascular y prevenir la enfermedad vascular","volume":"43","author":"Ortiz","year":"2023","journal-title":"Nefrolog\u00eda"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"140","DOI":"10.5694\/mja2.51361","article-title":"Competing risks of death and kidney failure in a cohort of Australian adults with severe chronic kidney disease","volume":"216","author":"Jose","year":"2022","journal-title":"Med. J. Aust."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nefro.2019.10.005","article-title":"Burden and challenges of heart failure in patients with chronic kidney disease. A call to action","volume":"40","author":"Ravassa","year":"2020","journal-title":"Nefrolog\u00eda"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(19)32563-2","article-title":"Acute kidney injury","volume":"394","author":"Ronco","year":"2019","journal-title":"Lancet"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrneph.2017.2","article-title":"Acute kidney disease and renal recovery: Consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup","volume":"13","author":"Chawla","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2215\/CJN.07201009","article-title":"Renal Angina","volume":"5","author":"Goldstein","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1681\/ASN.2010010128","article-title":"Albuminuria and estimated glomerular filtration rate independently associate with acute kidney injury","volume":"21","author":"Grams","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/S0140-6736(10)61271-8","article-title":"Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: A cohort study","volume":"376","author":"James","year":"2010","journal-title":"Lancet"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1053\/j.ajkd.2015.02.338","article-title":"A meta-analysis of the association of estimated GFR, albuminuria, diabetes mellitus, and hypertension with acute kidney injury","volume":"66","author":"James","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e935455","DOI":"10.12659\/MSM.935455","article-title":"Microalbuminuria Complicated with Low Estimated Glomerular Filtration Rate: Early Risk Factors for Contrast-Induced Acute Kidney Injury After Coronary Intervention","volume":"28","author":"Hu","year":"2022","journal-title":"Med. Sci. Monit."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/j.jvca.2015.05.194","article-title":"Urinary Albumin Levels Predict Development of Acute Kidney Injury After Pediatric Cardiac Surgery: A Prospective Observational Study","volume":"30","author":"Sugimoto","year":"2016","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jtcvs.2011.09.023","article-title":"Preoperative proteinuria predicts acute kidney injury in patients undergoing cardiac surgery","volume":"143","author":"Coca","year":"2012","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Wu, V.C., Huang, T.M., Wu, P.C., Wang, W.J., Chao, C.T., Yang, S.Y., Shiao, C.C., Hu, F.C., Lai, C.F., and Lin, Y.F. (2012). Preoperative proteinuria is associated with long-term progression to chronic dialysis and mortality after coronary artery bypass grafting surgery. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0027687"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2215\/CJN.13421211","article-title":"Association of postoperative proteinuria with AKI after cardiac surgery among patients at high risk","volume":"7","author":"Molnar","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e182009","DOI":"10.1001\/jamasurg.2018.2009","article-title":"Association Between Preoperative Proteinuria and Postoperative Acute Kidney Injury and Readmission","volume":"153","author":"Wahl","year":"2018","journal-title":"JAMA Surg."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000368902","article-title":"Association of de novo Dipstick Albuminuria with Severe Acute Kidney Injury in Critically Ill Septic Patients","volume":"128","author":"Neyra","year":"2015","journal-title":"Nephron Clin. Pract."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijcard.2015.06.019","article-title":"Spot urine albumin to creatinine ratio outperforms novel acute kidney injury biomarkers in patients with acute myocardial infarction","volume":"197","author":"Tziakas","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/nep.12637","article-title":"Dipstick albuminuria and acute kidney injury recovery in critically ill septic patients","volume":"21","author":"Neyra","year":"2016","journal-title":"Nephrology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.kint.2017.10.017","article-title":"Pre-admission proteinuria impacts risk of non-recovery after dialysis-requiring acute kidney injury","volume":"93","author":"Lee","year":"2018","journal-title":"Kidney Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.2215\/CJN.00910116","article-title":"Urinary biomarkers at the time of AKI diagnosis as predictors of progression of AKI among patients with acute cardiorenal syndrome","volume":"11","author":"Chen","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1681\/ASN.2011090907","article-title":"Biomarkers predict progression of acute kidney injury after cardiac surgery","volume":"23","author":"Koyner","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM199811123392007","article-title":"Pathophysiology of Progressive Nephropathies","volume":"339","author":"Remuzzi","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.ajkd.2020.11.026","article-title":"CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden","volume":"78","author":"Swartling","year":"2021","journal-title":"Am. J. Kidney Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"912","DOI":"10.2215\/CJN.11971116","article-title":"Albuminuria, proteinuria, and renal disease progression in children with CKD","volume":"12","author":"Fuhrman","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/jama.2010.39","article-title":"Relation between Kidney Function, Proteinuria, and Adverse Outcomes","volume":"303","author":"Hemmelgarn","year":"2010","journal-title":"JAMA"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2215\/CJN.07650711","article-title":"Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function","volume":"7","author":"Zoppini","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jama.2011.451","article-title":"A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure","volume":"305","author":"Tangri","year":"2011","journal-title":"JAMA"},{"key":"ref_58","unstructured":"(2023, December 28). The Kidney Failure Risk Equation. Available online: https:\/\/kidneyfailurerisk.com\/."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jama.2015.18202","article-title":"Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis","volume":"315","author":"Tangri","year":"2016","journal-title":"JAMA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S2213-8587(18)30314-0","article-title":"Change in albuminuria as a surrogate endpoint for progression of kidney disease: A meta-analysis of treatment effects in randomised clinical trials","volume":"7","author":"Heerspink","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/dom.15030","article-title":"Change in albuminuria as a surrogate endpoint for cardiovascular and renal outcomes in patients with diabetes","volume":"25","author":"Palmer","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"ref_62","unstructured":"Race, G.A., Scheifley, C.H., and Edwards, J.E. (2023, December 28). Albuminuria in Congestive Heart Failure. Available online: https:\/\/www.ahajournals.org\/doi\/pdf\/10.1161\/01.CIR.13.3.329."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000166727","article-title":"Proteinuria in Congestive Heart Failure","volume":"3","author":"Albright","year":"1983","journal-title":"Am. J. Nephrol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of Venous Congestion for Worsening of Renal Function in Advanced Decompensated Heart Failure","volume":"53","author":"Mullens","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.jacc.2016.02.058","article-title":"Reduced Cardiac Index Is Not the Dominant Driver of Renal Dysfunction in Heart Failure","volume":"67","author":"Hanberg","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMra064398","article-title":"Normotensive Ischemic Acute Renal Failure","volume":"357","author":"Abuelo","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehx035","article-title":"Renal sodium avidity in heart failure: From pathophysiology to treatment strategies","volume":"38","author":"Mullens","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_68","first-page":"175","article-title":"Renal Compression in Heart Failure: The Renal Tamponade Hypothesis","volume":"10","author":"Boorsma","year":"2022","journal-title":"Heart Fail."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ehf2.13118","article-title":"Congestive nephropathy: A neglected entity? Proposal for diagnostic criteria and future perspectives","volume":"8","author":"Assmus","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/eurheartj\/ehac528","article-title":"Albuminuria as a marker of systemic congestion in patients with heart failure","volume":"44","author":"Boorsma","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13098-022-00824-x","article-title":"Albuminuria but not low eGFR is closely associated with atherosclerosis in patients with type 2 diabetes: An observational study","volume":"14","author":"Wang","year":"2022","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/01.CIR.0000139860.33974.28","article-title":"Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients with Nephropathy","volume":"110","author":"Remuzzi","year":"2004","journal-title":"Circulation"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/ejhf.778","article-title":"The association of chronic kidney disease and microalbuminuria with heart failure with preserved vs. reduced ejection fraction","volume":"19","author":"Nayor","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1053\/j.ajkd.2012.03.011","article-title":"Combined Association of Albuminuria and Cystatin C\u2013Based Estimated GFR with Mortality, Coronary Heart Disease, and Heart Failure Outcomes: The Atherosclerosis Risk in Communities (ARIC) Study","volume":"60","author":"Waheed","year":"2012","journal-title":"Am. J. Kidney Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2337\/diacare.23.3.377","article-title":"Enalapril prevents clinical proteinuria in diabetic patients with low ejection fraction","volume":"23","author":"Capes","year":"2000","journal-title":"Diabetes Care"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cjca.2019.09.001","article-title":"Albuminuria: Associated with Heart Failure Severity and Impaired Clinical Outcomes","volume":"36","author":"Shuvy","year":"2020","journal-title":"Can. J. Cardiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.286.4.421","article-title":"Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic Individuals","volume":"286","author":"Gerstein","year":"2001","journal-title":"JAMA"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000490954","article-title":"Trace Albumin in the Urine Dipstick Test is Associated with Coronary Artery Calcification in Korean Adults","volume":"140","author":"Song","year":"2018","journal-title":"Nephron"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2016.04.013","article-title":"Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial","volume":"178","author":"Clare","year":"2016","journal-title":"Am. Heart J."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Ha, J.T., Freedman, S.B., Kelly, D.M., Neuen, B.L., Perkovic, V., Jun, M., and Badve, S.V. (2023). Kidney Function, Albuminuria, and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis. Am. J. Kidney Dis., in press.","DOI":"10.1053\/j.ajkd.2023.07.023"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2020.06.019","article-title":"KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease","volume":"98","author":"Disease","year":"2020","journal-title":"Kidney Int."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","article-title":"KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease","volume":"99","author":"Cheung","year":"2021","journal-title":"Kidney Int."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureDeveloped by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3317\/jraas.2002.042","article-title":"Between-patient differences in the renal response to renin-angiotensin system intervention: Clue to optimising renoprotective therapy?","volume":"3","author":"Laverman","year":"2002","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.kint.2021.03.033","article-title":"A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy","volume":"100","author":"Wheeler","year":"2021","journal-title":"Kidney Int."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2337\/dc22-1699","article-title":"Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial","volume":"46","author":"Curovic","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1136\/bmj.321.7274.1440","article-title":"Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: The candesartan and lisinopril microalbuminuria (CALM) study","volume":"321","author":"Mogensen","year":"2000","journal-title":"BMJ"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archinte.1996.00440030080010","article-title":"Long-term Renoprotective Effect of Angiotensin-converting Enzyme Inhibition in Non\u2014Insulin-dependent Diabetes Mellitus: A 7-Year Follow-up Study","volume":"156","author":"Ravid","year":"1996","journal-title":"Arch. Intern. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-118-8-199304150-00001","article-title":"Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients","volume":"118","author":"Ravid","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1056\/NEJMoa042274","article-title":"Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy","volume":"351","author":"Barnett","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"i438","DOI":"10.1136\/bmj.i438","article-title":"Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: Systematic review and meta-analysis of randomized trials","volume":"352","author":"Bangalore","year":"2016","journal-title":"BMJ"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41581-022-00535-6","article-title":"Kidney and heart failure outcomes associated with SGLT2 inhibitor use","volume":"18","author":"Heerspink","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1007\/s00125-018-4670-7","article-title":"SGLT2 inhibitors and mechanisms of cardiovascular benefit: A state-of-the-art review","volume":"61","author":"Verma","year":"2018","journal-title":"Diabetologia"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.34067\/KID.0001172021","article-title":"eGFR Decline after SGLT2 Inhibitor Initiation: The Tortoise and the Hare Reimagined","volume":"2","author":"Weinstein","year":"2021","journal-title":"Kidney360"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1161\/CIRCULATIONAHA.119.040514","article-title":"The Serendipitous Story of SGLT2 Inhibitors in Heart Failure: New Insights from DECLARE-TIMI 58","volume":"139","author":"Verma","year":"2019","journal-title":"Circulation"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"16976","DOI":"10.1161\/JAHA.120.016976","article-title":"Short-term changes in albuminuria and risk of cardiovascular and renal outcomes in type 2 diabetes mellitus: A post hoc analysis of the empa-reg outcome trial","volume":"9","author":"Waijer","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S2213-8587(21)00243-6","article-title":"Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: A prespecified analysis from the DAPA-CKD trial","volume":"9","author":"Jongs","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1681\/ASN.2020050723","article-title":"Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A PostHoc Analysis from the CREDENCE Trial","volume":"31","author":"Oshima","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00592-022-02022-7","article-title":"Baseline eGFR, albuminuria and renal outcomes in patients with SGLT2 inhibitor treatment: An updated meta-analysis","volume":"60","author":"Ma","year":"2023","journal-title":"Acta Diabetol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"G\u00f3rriz, J.L., Soler, M.J., Navarro-Gonz\u00e1lez, J.F., Garc\u00eda-Carro, C., Puchades, M.J., D\u2019marco, L., Castelao, A.M., Fern\u00e1ndez-Fern\u00e1ndez, B., Ortiz, A., and G\u00f3rriz-Zambrano, C. (2020). GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Call of Attention to Nephrologists. J. Clin. Med., 9.","DOI":"10.3390\/jcm9040947"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3389\/fphar.2020.00967","article-title":"GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms","volume":"11","author":"Kawanami","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1111\/dom.14776","article-title":"Effect of glucagon-like peptide 1 receptor agonists on albuminuria in adult patients with type 2 diabetes mellitus: A systematic review and meta-analysis","volume":"24","author":"Yuan","year":"2022","journal-title":"Diabetes Obes. Metab."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/ckj\/sfac274","article-title":"Tirzepatide and prevention of chronic kidney disease","volume":"16","author":"Bosch","year":"2023","journal-title":"Clin. Kidney J."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Karakasis, P., Patoulias, D., Fragakis, N., Klisic, A., and Rizzo, M. (Diabetes Obes. Metab., 2023). Effect of Tirzepatide on Albuminuria Levels and Renal Function in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Multilevel Meta-Analysis, Diabetes Obes. Metab., early view.","DOI":"10.1111\/dom.15410"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/eurheartj\/ehaa736","article-title":"Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine","volume":"42","author":"Agarwal","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/ndt\/gfs429","article-title":"Renoprotective effects of mineralocorticoid receptor blockers in patients with proteinuric kidney diseases","volume":"28","author":"Morales","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S2213-8587(14)70194-9","article-title":"Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: A double-blind, randomised, placebo-controlled trial","volume":"2","author":"Ando","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Romero-Gonz\u00e1lez, G., Bover, J., Arrieta, J., Salera, D., Troya, M., Graterol, F., Ure\u00f1a-Torres, P., Cozzolino, M., Di Lullo, L., and Cipp\u00e0, P.E. (2022). The \u201cFIFTY SHADOWS\u201d of the RALES Trial: Lessons about the Potential Risk of Dietary Potassium Supplementation in Patients with Chronic Kidney Disease. J. Clin. Med., 11.","DOI":"10.3390\/jcm11143970"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.aprim.2009.10.024","article-title":"La sombra del RALES es alargada","volume":"42","author":"Pereira","year":"2010","journal-title":"Aten. Primaria"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/cmdc.201200081","article-title":"Discovery of BAY 94-8862: A nonsteroidal antagonist of the mineralocorticoid receptor for the treatment of cardiorenal diseases","volume":"7","author":"Kuhl","year":"2012","journal-title":"ChemMedChem"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/jama.2015.10081","article-title":"Effect of Finerenone on Albuminuria in Patients with Diabetic Nephropathy: A Randomized Clinical Trial","volume":"314","author":"Bakris","year":"2015","journal-title":"JAMA"},{"key":"ref_116","first-page":"20","article-title":"Efecto de la finerenona sobre la albuminuria en pacientes con nefropat\u00eda diab\u00e9tica. \u00bfGrandes esperanzas en tiempos dif\u00edciles?","volume":"8","year":"2016","journal-title":"Nefrolog\u00eda"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.7326\/M23-1023","article-title":"Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes: A Mediation Analysis","volume":"176","author":"Agarwal","year":"2023","journal-title":"Ann. Intern. Med."},{"key":"ref_120","first-page":"sfad249","article-title":"Additive effects of dapagliflozin and finerenone on albuminuria in non-diabetic CKD: An open-label randomized clinical trial","volume":"17","author":"Thomsen","year":"2023","journal-title":"Clin. Kidney J."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.kint.2022.06.013","article-title":"Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: An update based on rapidly emerging new evidence","volume":"102","author":"Rossing","year":"2022","journal-title":"Kidney Int."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/3\/777\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:51:10Z","timestamp":1760104270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/3\/777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":121,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["jcm13030777"],"URL":"https:\/\/doi.org\/10.3390\/jcm13030777","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,29]]}}}